This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Biogen, Apellis filed HSR April 10, expiration is May 11

( April 14, 2026, 12:25 GMT | Official Statement) -- MLex Summary: Biogen and Appellis filed their Hart-Scott-Rodino premerger notification and report forms with the US Federal Trade Commission and US Department of Justice on April 10, 2026, Apellis said in a filing with the US Securities and Exchange Commission. Expiration of the 30-day waiting period is set for just before midnight on May 11. Excerpt....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login